US loss of exclusivity · Cardiometabolic

Wegovy

Novo Nordisk

2032US generics from
2025Today: 20262037
2025 worldwide sales
≈$12.0B
Date basis
Company guidance
US generics
Filed with the FDA
Medicare price
−71% from 2027
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Wegovy timeline →